Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection
Abstract Current COVID-19 vaccines prevent severe disease, but do not induce mucosal immunity or prevent infection with SARS-CoV-2, especially with recent variants. Furthermore, serum antibody responses wane soon after immunization. We assessed the immunogenicity and protective efficacy of an experi...
Main Authors: | Béré K. Diallo, Caitlín Ní Chasaide, Ting Y. Wong, Pauline Schmitt, Katherine S. Lee, Kelly Weaver, Olivia Miller, Melissa Cooper, Seyed D. Jazayeri, F. Heath Damron, Kingston H. G. Mills |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-023-00665-3 |
Similar Items
-
Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice
by: Nathaniel A. Rader, et al.
Published: (2024-10-01) -
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
by: Ting Y. Wong, et al.
Published: (2022-03-01) -
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
by: Pratima Kumari, et al.
Published: (2021-01-01) -
Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2
by: Mariette Barbier, et al.
Published: (2022-08-01) -
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice.
by: Katherine S Lee, et al.
Published: (2022-01-01)